NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Magnus Dillon
Institute of Cancer Research University of London - London / United Kingdom
Others
AD Scientific Index ID: 1244686
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Magnus Dillon's MOST POPULAR ARTICLES
1-)
Inflammatory microenvironment remodelling by tumour cells after radiotherapyM McLaughlin, EC Patin, M Pedersen, A Wilkins, MT Dillon, AA Melcher, ...Nature Reviews Cancer 20 (4), 203-217, 20202532020
2-)
ATR inhibition potentiates the radiation-induced inflammatory tumor microenvironmentMT Dillon, KF Bergerhoff, M Pedersen, H Whittock, E Crespo-Rodriguez, ...Clinical Cancer Research 25 (11), 3392-3403, 20191262019
3-)
Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric MicronucleiRadiosensitization by AZD6738MT Dillon, HE Barker, M Pedersen, H Hafsi, SA Bhide, KL Newbold, ...Molecular cancer therapeutics 16 (1), 25-34, 2017982017
4-)
Selective targeting of the G2/M cell cycle checkpoint to improve the therapeutic index of radiotherapyMT Dillon, JS Good, KJ HarringtonClinical oncology 26 (5), 257-265, 20141102014
5-)
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single …MT Dillon, Z Boylan, D Smith, J Guevara, K Mohammed, C Peckitt, ...Clinical and Translational Radiation Oncology 12, 16-20, 2018832018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept